Kern Ralph Dr. Insider Profile

11 Followers
Kern Ralph Dr., COO and Chief Medical Officer at Brainstorm Cell Therapeutics, holds 151.54K shares in Brainstorm Cell Therapeutics (Ticker: BCLI).
Kern Ralph Dr.

Kern Ralph Dr.
Brainstorm Cell Therapeutics (BCLI)
COO and Chief Medical Officer

Not Ranked
Kern Ralph Dr. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$796K
100.00%
A breakdown of Kern Ralph Dr.'s holdings

Insider Roles

Brainstorm Cell Therapeutics
(BCLI)
COO and Chief Medical Officer
Roles that Kern Ralph Dr. holds in companies

Most Profitable Insider Trade

Stock:
Brainstorm Cell Therapeutics
(BCLI)
Rating:Informative Buy
Date:Dec 27, 2019 - Dec 27, 2020
Return:+28.30%
The most profitable trade made by Kern Ralph Dr.

Kern Ralph Dr.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Brainstorm Cell Therapeutics
Mar 06, 2020
COO and Chief Medical Officer
Uninformative Buy
$795.59K
Success Rate for BCLI
1 out of 1 profitable transactions on BCLI
100%
Average Return for BCLI
Average return per transaction on BCLI
+28.30%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Mar 06, 2017
Uninformative Buy
$0.00
-
$0.00
Mar 19, 2018
Uninformative Buy
$17.95K
-
$3.59
Mar 26, 2018
Uninformative Buy
$0.00
-
$0.00
Mar 08, 2019
Uninformative Buy
$0.00
-
$0.00
Dec 27, 2019
Informative Buy
$11.64K
-
$3.88
+28.30%
List of latest transactions for each holding click on a transaction to see Kern Ralph Dr.'s performance on stock

Kern Ralph Dr. insider profile FAQ

What is the percentage of profitable transactions made by Kern Ralph Dr.?
The percentage of profitable transactions made by Kern Ralph Dr. is ―.
    What is the average return per transaction made by Kern Ralph Dr.?
    The average return per transaction made by Kern Ralph Dr. is ―.
      What stocks does Kern Ralph Dr. hold?
      Kern Ralph Dr. holds: BCLI stocks.
        What was Kern Ralph Dr.’s latest transaction?
        Kern Ralph Dr. latest transaction was an Uninformative Buy of ―.
          What was Kern Ralph Dr.'s most profitable transaction?
          Kern Ralph Dr.’s most profitable transaction was an Informative Buy of BCLI stock on December 27, 2019. The return on the trade was 28.30%.
            What is Kern Ralph Dr.'s role in Brainstorm Cell Therapeutics?
            Kern Ralph Dr.'s role in Brainstorm Cell Therapeutics is COO and Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.